Company Cash Funds: Avidity Biosciences Inc (RNA)

Graphic logo of Avidity Biosciences, Inc. (RNA)

Avidity Biosciences (RNA) is developing a promising RNA therapy with the potential for massive operating leverage. The cash balance on the GURU.Markets daily chart reflects the dynamics of these resources, and this figure equals 0.23. Avidity Biosciences relies on a genetic treatment ecosystem for rare myopathies under strict FDA supervision; however, financial stability remains low due to dependence on regulatory approvals.

RNA - Avidity Biosciences Inc Company Cash on Hand over the range 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company Avidity Biosciences Inc (RNA)

- company stock exchange capitalization indicators:
Fundamental valuation:RNA Avidity Biosciences, Inc.
Signature product of Avidity Biosciences, Inc.

Monitoring real liquid balances, which record the actual availability of funds in accounts without accounting lags, is critical for constructing a defensive portfolio. For Avidity Biosciences (RNA), this metric determines the ability to fund costly R&D research in RNA therapy and AOC conjugates; therefore, the company's cash dynamics serve as a direct indicator of the viability of its biotechnological pipeline.

Who Avidity Biosciences competes with

Company Cash Volume TEM|QGEN - Company Cash Reserve|ionispharma.com - Company Cash on Hand|Company Cash Balance RGEN|CRSP: Company Cash on Hand|GeneDx Corp (WGS) - Company Cash on Hand|RARE: Company Cash Volume|BEAM - Company Liquid Assets|SRPT (Sarepta Therapeutics) - Company Cash Volume|Company Cash on Hand Twist Bioscience Inc (TWST)|Company Cash Volume TXG|Company Liquid Assets Intellia|Stoke - Company Cash on Hand|BLFS: Company Cash and Cash Equivalents|Wave Life Sciences Corp - Company Cash Volume|Maze Therapeutics, Inc. (MAZE) - Company Cash on Hand|Sionna Therapeutics Inc (SION) - Company Cash Funds|Company Cash on Hand Prime Medicine Corp|Company Cash Funds tayshagtx.com|QURE - Company Cash Position|Company Cash on Hand MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Company Cash Position|Company Cash Volume SLDB (Solid Biosciences Inc.)|Company Cash Balance OCGN|PacBio Corp - Company Cash Volume|Benitec Biopharma Inc. (BNTC) - Company Cash on Hand|DSGN: Company Cash Volume|Company Cash and Cash Equivalents RCKT|Company Cash on Hand FDMT|Company Cash and Cash Equivalents LXEO (Lexeo Therapeutics)|Company Cash Volume KRRO|Editas Medicine, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Silence Therapeutics Inc. SLN|Company Cash Volume ProQR Therapeutics N.V. PRQR|CDXS: Company Cash on Hand|Company Cash Position Sangamo (SGMO)|NAUT (Nautilus Bio) - Company Cash on Hand|MGX - Company Liquid Assets|DTIL (Precision BioSciences Inc.) - Company Cash Volume|generationbio.com (GBIO) - Company Liquid Assets|Company Cash Funds Boundless Bio Inc (BOLD)|Company Cash Volume Exicure Inc. (XCUR)|Company Cash Funds imunon.com IMNN|Company Cash Volume Phio Pharmaceuticals PHIO|Mustang Bio Inc - Company Cash Volume|Company Cash Reserve transcodetherapeutics.com|BNGO: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume